Close
American Drug Delivery & Formulation Summit
Xylem

CluePoints Announces Amit Patel as New CFO

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

TRT Safety: What Current Research Actually Says About Long-Term Use

Testosterone replacement therapy has spent years caught between two...

Merck Signs Voluntary Licensing Deals for Oral HIV Pill

Merck has entered into seven voluntary licensing agreements with...

Trump Proposes Generic Drug Tariffs to Drive Reshoring Effort

President Donald Trump announced plans to implement massive generic...
- Advertisement -

RBQM leader, CluePoints, has announced that Amit Patel will join as the new Chief Financial Officer (CFO) amid ambitious growth plans and organizational changes as it continues to drive the paradigm shift in how world-class risk-based quality management (RBQM) and data quality oversight is delivered. With a projected outlook of a 25% increase in staff numbers, and a 35%+ increase in revenues in 2023, CluePoints is reorganizing for further growth, scale, and focus on achieving its goals.

Amit Patel is an experienced strategic and commercial SaaS CFO and entrepreneur who will work with the Leadership Team at CluePoints to take the business to the next level as a multi-national SaaS leader. Amit has many years of experience building and scaling SaaS companies through significant go-to-market expansion, continued professionalization of the organization through systems and people and corporate development via M&A where opportunities arise.

CluePointsโ€™ former VP of People, Celine Daubresse, will be promoted to Chief People Officer reporting to the CEO to provide increased focus on all people aspects as the company evolves and grows.

Francois Torche will lead a single, consolidated Product, Engineering, and Research organization to execute the product vision, strategy, and direction as CluePointsโ€™ Chief Product & Technology Officer.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Latest stories

Related stories

TRT Safety: What Current Research Actually Says About Long-Term Use

Testosterone replacement therapy has spent years caught between two...

Merck Signs Voluntary Licensing Deals for Oral HIV Pill

Merck has entered into seven voluntary licensing agreements with...

Trump Proposes Generic Drug Tariffs to Drive Reshoring Effort

President Donald Trump announced plans to implement massive generic...

What to Look for in a Supplement Manufacturer

Finding a supplement manufacturer is relatively easy. Finding one...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป